Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
Authors
Keywords
Down syndrome, Alzheimer’s disease, Dementia, Neurofilament light, Biomarker
Journal
Alzheimers Research & Therapy
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-04-19
DOI
10.1186/s13195-018-0367-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome
- (2018) Panagiotis Zis et al. FREE RADICAL BIOLOGY AND MEDICINE
- Predictors of Age of Diagnosis and Survival of Alzheimer’s Disease in Down Syndrome
- (2017) Amanda Sinai et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity
- (2017) Panagiotis Zis et al. NEUROSCIENCE LETTERS
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- The pattern of amyloid accumulation in the brains of adults with Down syndrome
- (2016) Tiina Annus et al. Alzheimers & Dementia
- An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
- (2016) M. Florencia Iulita et al. Alzheimers & Dementia
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration
- (2016) Henrik Zetterberg NEURON
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome
- (2015) Frances K. Wiseman et al. NATURE REVIEWS NEUROSCIENCE
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome
- (2014) Sigan L. Hartley et al. BRAIN
- Memory Decline in Down Syndrome and Its Relationship to iPF2alpha, a Urinary Marker of Oxidative Stress
- (2014) Panagiotis Zis et al. PLoS One
- The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID
- (2008) A. Strydom et al. PSYCHOLOGICAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started